Serina Therapeutics, Inc.SERNYSE
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank63
3Y CAGR+84.6%
5Y CAGR+9.3%
Studio
Year-over-Year Change

Cash on hand plus short-term liquid investments

3Y CAGR
+84.6%/yr
vs -47.0%/yr prior
5Y CAGR
+9.3%/yr
Recent acceleration
Acceleration
+131.5pp
Accelerating
Percentile
P63
Within normal range
vs 5Y Ago
1.6x
Solid growth
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2024$3.67M-51.8%
2023$7.62M+1081.2%
2022$645000.00+10.4%
2021$584000.00+10.8%
2020$527000.00-77.6%
2019$2.35M-64.9%
2018$6.71M-9.1%
2017$7.38M+2747.5%
2016$259000.00-